Betrixaban: New Oral Blood Thinner Cleared by FDA

The U.S. Food and Drug Administration has granted Portola Pharmaceuticals permission to market a a new oral anticoagulant or “blood thinner”called betrixaban (BevyxXa®). The medication is indicated for use for the prevention of venous thromboembolism and pulmonary embolism in acutely ill patients who are not undergoing surgery, but are at risk for venous thromboembolism due…

Blood Clots Changed Our Lives: Corey Capman’s Story, as told by His Mother

The personal story below is intended for informational purposes only. The National Blood Clot Alliance (NBCA) holds the rights to all content that appears on its website. The use by another organization or online group of any content on NBCA’s website, including patient stories that appear here, does not imply that NBCA is connected to…

Changing My Outlook on Life: Natalie Atkins’ Blood Clot Story

The personal story below is intended for informational purposes only. The National Blood Clot Alliance (NBCA) holds the rights to all content that appears on its website. The use by another organization or online group of any content on NBCA’s website, including the patient stories that appear here, does not imply that NBCA is connected…